144 related articles for article (PubMed ID: 36942965)
1. Local Control and Survival Outcomes After Stereotactic Radiosurgery for Brain Metastases From Gastrointestinal Primaries: An International Multicenter Analysis.
Singh R; Bowden G; Mathieu D; Perlow HK; Palmer JD; Elhamdani S; Shepard M; Liang Y; Nabeel AM; Reda WA; Tawadros SR; Abdelkarim K; El-Shehaby AMN; Emad RM; Elazzazi AH; Warnick RE; Gozal YM; Daly M; McShane B; Addis-Jackson M; Karthikeyan G; Smith S; Picozzi P; Franzini A; Kaisman-Elbaz T; Yang HC; Wei Z; Legarreta A; Hess J; Templeton K; Pikis S; Mantziaris G; Simonova G; Liscak R; Peker S; Samanci Y; Chiang V; Niranjan A; Kersh CR; Lee CC; Trifiletti DM; Lunsford LD; Sheehan JP
Neurosurgery; 2023 Sep; 93(3):592-598. PubMed ID: 36942965
[TBL] [Abstract][Full Text] [Related]
2. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
3. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery in the treatment of brain metastases from gastrointestinal primaries.
Trifiletti DM; Patel N; Lee CC; Romano AM; Sheehan JP
J Neurooncol; 2015 Sep; 124(3):439-46. PubMed ID: 26186901
[TBL] [Abstract][Full Text] [Related]
5. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
6. Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients.
Lehrer EJ; Ahluwalia MS; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Jones BM; Green S; Sheehan JP; Trifiletti DM
J Neurosurg; 2023 May; 138(5):1178-1187. PubMed ID: 36115055
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients.
Pontoriero A; Conti A; Iatì G; Mondello S; Aiello D; Rifatto C; Risoleti E; Mazzei M; Tomasello F; Pergolizzi S; De Renzis C
Neurosurg Rev; 2016 Jul; 39(3):495-504. PubMed ID: 27106896
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
[TBL] [Abstract][Full Text] [Related]
10. The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy.
Davis JN; Medbery C; Sharma S; Danish A; Mahadevan A
Radiat Oncol; 2013 Nov; 8():275. PubMed ID: 24274599
[TBL] [Abstract][Full Text] [Related]
11. Impact of time of day on outcomes after stereotactic radiosurgery for non-small cell lung cancer brain metastases.
Badiyan SN; Ferraro DJ; Yaddanapudi S; Drzymala RE; Lee AY; Silver SA; Dyk P; DeWees T; Simpson JR; Rich KM; Robinson CG
Cancer; 2013 Oct; 119(19):3563-9. PubMed ID: 23839874
[TBL] [Abstract][Full Text] [Related]
12. The role of radiosurgery for multiple brain metastases.
Cho KH; Hall WA; Gerbi BJ; Higgins PD
Neurosurg Focus; 2000 Aug; 9(2):e2. PubMed ID: 16836288
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
14. Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA.
Kessel KA; Deichl A; Gempt J; Meyer B; Posch C; Diehl C; Zimmer C; Combs SE
Clin Transl Oncol; 2021 Oct; 23(10):2020-2029. PubMed ID: 33993415
[TBL] [Abstract][Full Text] [Related]
15. Utility of graded prognostic assessment in evaluation of patients with brainstem metastases treated with radiosurgery.
Joshi R; Johnson MD; Maitz A; Marvin KS; Olson RE; Grills IS
Clin Neurol Neurosurg; 2016 Aug; 147():30-3. PubMed ID: 27262115
[TBL] [Abstract][Full Text] [Related]
16. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
[TBL] [Abstract][Full Text] [Related]
17. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
18. Treatment of brain metastases from gastrointestinal primaries: Comparing whole-brain radiotherapy and stereotactic radiosurgery in terms of survival.
Dincer S; Gurbuz D
North Clin Istanb; 2022; 9(1):47-56. PubMed ID: 35340309
[TBL] [Abstract][Full Text] [Related]
19. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
Rades D; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Nov; 110(10):2285-92. PubMed ID: 17922523
[TBL] [Abstract][Full Text] [Related]
20. Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection.
Kurtz G; Zadeh G; Gingras-Hill G; Millar BA; Laperriere NJ; Bernstein M; Jiang H; Ménard C; Chung C
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):137-42. PubMed ID: 24331660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
